On July 10, 2025, under the invitation by Department of Hematology of the First Affiliated Hospital (FAH) of Xi'an Jiaotong University (XJTU), Professor Wei Hui from Blood Diseases Hospital of Chinese Academy of Medical Sciences and Professor David Wald from Case Western Reserve University paid a visit to FAH for academic exchange, focusing on the cutting-edge frontiers in diagnosis and treatment of hematological diseases, especially the latest progress in the field of acute lymphoblastic leukemia (ALL) and cellular immunotherapy.

Professor He Pengcheng, Director of Department of Hematology, delivered an opening speech. In the thematic lecture session, Professor Wei Hui delivered a thematic lecture entitled "How I treat ALL", systematically shared the standardized diagnosis and treatment strategy and individualized management experience of ALL, and explicitly evaluated the clinical value of precision diagnosis and multidisciplinary collaboration. Professor David Wald contributed a lecture entitled "Strategies to Improve Cancer Cell Therapy", comprehensively demonstrated the technical optimization path of CAR-T cell therapy and the latest clinical translation results worldwide, and offered international frontier perspective.

Professor Gao Peng from Professor He Pengcheng’s team shared a complicated case report: a 64-year-old B-cell ALL (B-ALL) patient complicated with atrial fibrillation, hypertension and other primary diseases, scheduled to be treated with CAR-T cell therapy. For this complicated case, all participating experts conducted in-depth exchanges and discussions on the risk management, maintenance treatment protocol design and transplantation timing of CAR-T cell therapy. Professor Wei Hui and Professor David Wald combined international guidelines with clinical experience to put forward targeted suggestions. Subsequently, Professor David Wald delivered ward round for this patient and contributed valuable suggestions for subsequent treatment.